Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "2022"

1420 News Found

Lyka Labs posts Q2 FY24 loss at Rs. 48.65 lakhs
News | November 03, 2023

Lyka Labs posts Q2 FY24 loss at Rs. 48.65 lakhs

Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023


Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr
News | November 03, 2023

Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr

Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023


Dabur India posts Q2 FY24 consolidated PAT at Rs. 515.05 Cr
News | November 03, 2023

Dabur India posts Q2 FY24 consolidated PAT at Rs. 515.05 Cr

The company has posted net profit of Rs.978.93 crores for the 6 months period ended September 30, 2023


Lincoln Pharmaceuticals posts Q2 FY24 consolidated PAT at Rs. 27.65 Cr
News | November 03, 2023

Lincoln Pharmaceuticals posts Q2 FY24 consolidated PAT at Rs. 27.65 Cr

Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023


Dr Lal Path Labs posts Q2 FY24 consolidated PAT at Rs. 109.3 Cr
News | November 03, 2023

Dr Lal Path Labs posts Q2 FY24 consolidated PAT at Rs. 109.3 Cr

Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023


Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr
News | November 02, 2023

Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr

The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202


Sun Pharmaceutical Industries Q2 FY 24 consolidated PAT higher at Rs. 2375.51 Cr
News | November 02, 2023

Sun Pharmaceutical Industries Q2 FY 24 consolidated PAT higher at Rs. 2375.51 Cr

Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023


Mankind Pharma Q2 FY24 consolidated PAT higher at Rs. 501.02 Cr
News | November 01, 2023

Mankind Pharma Q2 FY24 consolidated PAT higher at Rs. 501.02 Cr

Mankind Pharma has reported total income of Rs. 2768.07 crores during the period ended September 30, 2023


Thyrocare Technologies posts Q2 FY24 consolidated PAT at Rs. 20.34 Cr
News | November 01, 2023

Thyrocare Technologies posts Q2 FY24 consolidated PAT at Rs. 20.34 Cr

Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023


Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr
News | November 01, 2023

Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr

Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023